Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and engaged in early discussions, they said. In February, Novo Holdings, the holding company of Novo Nordisk, acquired US-based publicly-listed contract development and manufacturing organisation Catalent for $16.5 billion.
RITES shares rally over 12% as stock trades ex-dividend, ex-bonus
RITES Share Price: The company announced a final dividend of Rs 5 per share and a 1:1 bonus share issue earlier in July for its